Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis

AIDS. 2010 Jan 16;24(2):328-30. doi: 10.1097/QAD.0b013e3283350f08.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / metabolism*
  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Antibiotics, Antitubercular / administration & dosage
  • HIV-2 / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Pyrrolidinones / administration & dosage
  • Pyrrolidinones / pharmacokinetics*
  • Raltegravir Potassium
  • Rifampin / administration & dosage
  • Tuberculosis / drug therapy*
  • Tuberculosis / immunology

Substances

  • Anti-HIV Agents
  • Antibiotics, Antitubercular
  • Pyrrolidinones
  • Raltegravir Potassium
  • Rifampin